Sign Out
No interaction studies with other medicinal products have been performed.
In vitro studies have shown that Olopatadine did not inhibit metabolic reactions that involve cytochrome P-450 isozymes 1A2, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A4. These results indicate that Olopatadine is unlikely to result in metabolic interactions with other concomitantly administered active substances.
Continue with Google